A Conversation with CBO Michael Simon

April 8, 2021

Primary Sidebar

CCR5 Antagonist RAP-103 Protects Synapses in Dementia May 29, 2024
RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression Jul 19, 2022
RAP-103 Benefits in Pain Published Jul 14, 2022
BioHealth Innovation Press Release Features Creative Bio-Peptides Nov 30, 2021
A Conversation with CBO Michael Simon Apr 8, 2021
NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE Sep 28, 2020
CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS Jan 20, 2020
CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT Jan 18, 2020

Rockville, MD
USA 20854

CCR5 Antagonist RAP-103 Protects Synapses in Dementia May 29, 2024
RAP-103 Inhibits Opioid-derived Dependence, Withdrawal and Respiratory Depression Jul 19, 2022
RAP-103 Benefits in Pain Published Jul 14, 2022
BioHealth Innovation Press Release Features Creative Bio-Peptides Nov 30, 2021
A Conversation with CBO Michael Simon Apr 8, 2021
NIH SBIR AWARD FOR SYNAPSE PROTECTING TREATMENTS FOR ALZHEIMER’S DISEASE Sep 28, 2020
CREATIVE BIO-PEPTIDES RECEIVES NIH HEAL AWARD FOR OPIOID ABUSE DISORDERS Jan 20, 2020
CREATIVE BIO-PEPTIDES and LEIDOS AWARDED US DOD CONTRACT Jan 18, 2020